(Press-News.org) https://doi.org/10.1016/j.apsb.2025.09.026
This new article publication from Acta Pharmaceutica Sinica B, discusses the discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model.
SARS-CoV-2 continues to propagate globally, posing non-negligible risks of severe COVID-19. Although several clinical antivirals and immunosuppressants offer crucial protection, there is a persistent need for additional therapeutic options to counter emerging viral variants and drug resistances. New strategies focusing on host targets, or simultaneously suppressing viral replication and inflammation, particularly require rigorous validation. Compared to established antiviral targets, PLpro presents an alternative actionable vulnerability in SARS-CoV-2 infection. Meanwhile, RIPK1 was pinpointed to enhance both viral replication and the resulting cytokine storm in host cells. However, inhibitors targeting PLpro or RIPK1 require further optimization for preclinical studies, and their combined efficacy in vivo has yet to be explored. The authors of this article report the discoveries of potent and selective PLpro inhibitors and RIPK1 inhibitors through high-throughput approaches. The lead compounds, SHY1643 and QY1892, demonstrated synergistic and robust effects in reducing the viral loads and cytokine release syndromes in SARS-CoV-2-infected mice. These findings establish a proof-of-concept combination therapy strategy for treating severe COVID-19, and provide promising leads for the clinical drug development.
Keywords: SARS-CoV-2, COVID-19, PLpro, RIPK1, Infective diseases, Cytokine storms, Small molecule inhibitors, Combination therapy
Graphical Abstract: available at https://ars.els-cdn.com/content/image/1-s2.0-S2211383525006276-ga1_lrg.jpg
High-throughput approaches-driven discovery of inhibitors, SHY1643 and QY1892, offers a promising combinational therapy for severe COVID-19 by synergistically targeting viral PLpro and host RIPK1.
# # # # # #
The Journal of the Institute of Materia Medica, the Chinese Academy of Medical Sciences and the Chinese Pharmaceutical Association.
For more information please visit https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b/
Editorial Board: https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b/editorial-board
APSB is available on ScienceDirect (https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b).
Submissions to APSB may be made using Editorial Manager® (https://www.editorialmanager.com/apsb/default.aspx).
CiteScore: 24.3
Impact Factor: 14.6 (Top 6 journal in the category of Pharmacology and pharmacy)
JIF without self-citation: 13.8
ISSN 2211-3835
# # # # #
Hengyue Shan, Yuzheng Zhou, Ying Qin, Taijie Guo, Xiao Zhang, Huaijiang Xiang, Qinyang He, Chen Shi, Dekang Li, Jingli Liu, Chunting Qi, Shi Chen, Jiajia Dong, Gang Xu, Ying Li, Zheng Zhang, Li Tan, Discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model, Acta Pharmaceutica Sinica B, Volume 16, Issue 1, 2026, Pages 387-405, ISSN 2211-3835, https://doi.org/10.1016/j.apsb.2025.09.026
END
https://doi.org/10.1016/j.apsb.2025.11.026
This new article publication from Acta Pharmaceutica Sinica B, discusses how neg-entropy is the true drug target for chronic diseases.
Molecular mechanisms of chronic diseases are complicated, and this impedes drug target identification and subsequent drug discovery. Entropy increase in human body can be considered the root cause of chronic diseases. Accordingly, the inherent neg-entropic mechanisms, for instance the homeostatic mechanisms for metabolism, immunity, self-healing, etc., are true drug targets. Only very few ...
https://doi.org/10.1016/j.apsb.2025.09.037
This new article publication from Acta Pharmaceutica Sinica B, discusses an Oxygen-boosted dual-section microneedle patch for enhanced drug penetration and improved photodynamic and anti-inflammatory therapy in psoriasis.
Psoriasis is a prevalent chronic inflammatory skin disorder, characterized by epidermal thickening and an inflammatory hypoxic microenvironment, which significantly hinder drug penetration through the thickened skin and limit the efficacy of photodynamic therapy (PDT). The authors of this article ...
Sepsis is a leading global cause of hospital deaths, occurring when the body’s response to infection damages tissue and causes organs to fail. Africa bears the world’s highest burden of sepsis, with an estimated 48 million cases each year leading to about 11 million deaths. People living with HIV face the greatest risk of dying from the condition.
A new study has found that tuberculosis, a chronic bacterial lung disease, is a major and long-overlooked cause of deadly sepsis among people living with HIV. An associated Phase 3 clinical trial called the ATLAS study found that starting tuberculosis (TB) treatment ...
https://doi.org/10.1016/j.apsb.2025.10.027
This new article publication from Acta Pharmaceutica Sinica B, discusses how palmitoylation of Tfr1 enhances platelet ferroptosis and liver injury in heat stroke.
Heat stroke (HS) is a severe medical emergency characterized by coagulation and high mortality due to organ injury. This study identifies a novel mechanism in which platelet ferroptosis, driven by transferrin receptor 1 (Tfr1) palmitoylation, significantly contributes to liver injury in HS. ...
https://doi.org/10.1016/j.apsb.2025.10.028
This new article publication from Acta Pharmaceutica Sinica B, discusses how structure-guided design of picomolar-level macrocyclic TRPC5 channel inhibitors with antidepressant activity.
Recent advances in ion channel structural biology have enhanced structure-based drug design, yet lipid-occupied binding pockets—often large and flat—remain a major hurdle for developing selective small molecules. TRPC5, a brain-enriched channel regulating depression and anxiety, is a promising therapeutic target, but current preclinical candidates suffer from moderate off-target effects. To address ...
https://doi.org/10.1016/j.apsb.2025.11.025
This new article publication from Acta Pharmaceutica Sinica B, discusses therapeutic drug monitoring of biologics in inflammatory bowel disease.
Therapeutic drug monitoring (TDM) has emerged as a valuable tool for optimizing the use of biologics in inflammatory bowel disease (IBD). However, variations in focus, methodology, and recommendations among relevant guidelines and consensuses have contributed to inconsistencies in their quality. This guideline synthesizes current evidence to standardize TDM of biologics in IBD and improve patient ...
A new global review highlights that tackling climate change requires more than funding or innovation alone. Researchers emphasize that meaningful climate action depends on the coordinated integration of financial systems, technological solutions, and governance reforms. The study presents a comprehensive framework designed to help countries, especially developing nations, implement effective and equitable climate strategies.
Climate change is increasingly threatening ecosystems, economies, and human well-being worldwide. ...
Scientists have discovered that cyanobacteria, microscopic organisms best known for driving harmful algal blooms, may play a major role in spreading antibiotic resistance genes in coastal environments. The findings highlight a previously overlooked link between natural nutrient cycling and the global challenge of antibiotic resistance.
Antibiotic resistance genes enable bacteria to survive exposure to antibiotics, posing serious risks to public health, agriculture, and ecosystem stability. While these genes are widely detected in aquatic environments, their biological drivers and ecological roles have remained poorly understood.
In a new study examining ...
Chestnut Hill, Mass. (2/6/2026) – Children across the globe engage in a constellation of behaviors that support cooperation, an action critical to the survival of the human species, a team of Boston College researchers report today in the journal Science Advances.
The team from Associate Professor of Psychology Katherine McAuliffe’s Cooperation Lab surveyed children in the urban United States, rural Uganda, Canada, and Peru, and the hunter-horticulturalist indigenous Shuar of Ecuador.
The researchers found there are cross-cultural regularities in some aspects of the development ...
How do children learn to cooperate with others? A new cross-cultural study suggests that the answer depends less on universal rules and more on the social norms surrounding the child.
In the study, researchers examined how more than 400 children ages five to 13 from the United States, Canada, Peru, Uganda and the Shuar communities of Ecuador behaved in situations involving fairness, trust, forgiveness and honesty. The team also surveyed children and adults in each community to understand what people believed was the “right” thing to do.
The ...
